Elligo Health Research®

Elligo-Health-Research-R.jpg

Only Elligo Health Research® Optimizes the Intersection of Healthcare and Research to Accelerate Clinical Trials.

Elligo accelerates clinical trials with early, direct access to diverse patients who are pre-vetted for protocol inclusion through HIPAA-compliant identified EHR data, our easy-to-use proprietary technology that ensures data integrity from patient ID to study close, and our Research Partner Services that enable healthcare practices and research sites to seamlessly participate in clinical trials.

Elligo’s adaptive engagement model, consisting of PatientSelect®, SiteSelect, Research Partner Services, and our proprietary technology portfolio provides access to the best patients, healthcare experts, and research solutions.

As the ultimate healthcare-enabling research organization, we optimize the intersection of healthcare and research, maintain the integrity of the trusted patient-physician relationship, and leverage electronic health records to accelerate the development of new pharmaceutical, biotechnology, and medical device and diagnostic products while bringing more patients clinical research as a care option.

Related Resources

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Content provided by Elligo Health Research®

Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants from underrepresented racial and ethnic populations, specifically Black or African American,...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Content provided by Elligo Health Research®

Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article to learn the four warning signs you should keep an eye out for, as they often spell operational and...